NASDAQ: IPHA
Innate Pharma Sa Stock Ownership - Who owns Innate Pharma Sa?

Insider buying vs selling

Have Innate Pharma Sa insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when IPHA insiders and whales buy or sell their stock.

IPHA Shareholders

What type of owners hold Innate Pharma Sa stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Exchange Traded Concepts LLC0.07%62,752$109.82kInstitution
Morgan Stanley0.05%43,524$76.17kInstitution
Citadel Advisors LLC0.03%24,267$42.47kInstitution
Millennium Management LLC0.02%15,326$26.82kInstitution
Ubs Group Ag0.01%9,001$15.75kInstitution
Gamma Investing LLC0.00%2,233$3.91kInstitution
Rhumbline Advisers0.00%675$1.18kInstitution
Barclays PLC0.00%307$537.25Institution
Optiver Holding Bv0.00%101$176.75Institution
Tower Research Capital LLC Trc0.00%3$5.25Institution

1 of 2

IPHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IPHA0.19%0.00%
THTX27.77%0.00%
CCCC78.01%21.99%Net SellingNet Buying
ASMB24.27%75.73%Net Buying
GALT11.50%88.50%Net BuyingNet Buying

Innate Pharma Sa Stock Ownership FAQ

Who owns Innate Pharma Sa?

Innate Pharma Sa (NASDAQ: IPHA) is owned by 0.19% institutional shareholders, 0.00% Innate Pharma Sa insiders, and 99.81% retail investors. Exchange Traded Concepts LLC is the largest individual Innate Pharma Sa shareholder, owning 62,752.00 shares representing 0.07% of the company. Exchange Traded Concepts LLC's Innate Pharma Sa shares are currently valued at $107.93k.

If you're new to stock investing, here's how to buy Innate Pharma Sa stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.